Delayed Clamping and Milking the Umbilical Cord in Preterm Infants

December 27, 2018 updated by: TriHealth Inc.

Delayed Clamping and Milking the Umbilical Cord Prior to Clamping in Preterm Infants and the Effect of Neonatal Outcomes

This is a randomized controlled trial that will compare the effects of delayed umbilical cord clamping to umbilical cord milking in preterm infants (less than 34 weeks gestation). The infants' hemoglobin and hematocrit levels in the Neonatal Intensive Care Unit (NICU) will be evaluated, as well as the rates of necrotizing enterocolitis, intraventricular hemorrhage, and blood transfusions. The hypothesis is that milking the umbilical cord prior to clamping is superior to simply delayed cord clamping, presumably providing an increased blood volume to the preterm neonate improving its outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The optimal timing for clamping the umbilical cord after birth in preterm infants has been a subject of controversy and debate for many years. It has been until recently the standard practice in ob/gyn to clamp the umbilical cord immediately post delivery to allow for immediate transition resuscitation of the neonate, especially in preterm infants. Due to the fact that optimal timing for cord clamping has yet to be definitively established in the preterm population, more information is needed. Immediate cord clamping, however, could preclude the infant from an extra boost in blood volume that may prove beneficial later in the newborn life. Directly comparing the recently recommended practice of delayed umbilical cord clamping to milking the umbilical cord prior to clamping has the potential to prove beneficial for the neonates in question, as well as change daily obstetrical practices. In this study all infants below 34 weeks will be randomized into one of two groups: delayed cord clamping and milking the umbilical cord prior to clamping. The decision was made not to include immediate cord clamping due to a recent American Congress of Obstetricians and Gynecologists (ACOG) recommendation that all preterm infants have their cord clamping be delayed. Their outcomes will be measured by serial hemoglobin and hematocrit levels while in the NICU, the incidence of necrotizing enterocolitis, incidence of intraventricular hemorrhage, and the need for neonatal blood transfusions.

Study Type

Interventional

Enrollment (Actual)

282

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45220
        • Good Samaritan TriHealth Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admitted to Labor & Delivery at Good Samaritan TriHealth Hospital in Cincinnati, Ohio with expected/possible preterm delivery between 23-34 weeks gestation
  • Care provided by Good Samaritan TriHealth Hospital's Faculty Medical Center or Tri-State Maternal Fetal Medicine

Exclusion Criteria:

  • Declined to participate
  • Known congenital anomalies
  • Precipitous delivery preventing completion of the protocol
  • Placental abruption around the time of or as indication for delivery
  • Mother has uterine rupture
  • Non reassuring fetal heart tracing (FHT) immediately prior/leading to delivery
  • Multiple gestation
  • Parvo B19
  • Infants known to be at risk of anemia due to isoimmunization (mother has red blood cell antibodies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Delayed Clamping

The American Congress of Obstetricians and Gynecologists (ACOG) recommends delayed cord clamping for preterm infants. Infants randomized to this group will follow the protocol below:

  1. Infant held at or below level of perineum (vaginal delivery) or incision (cesarean delivery)
  2. Once infant is delivered designated RN starts timer
  3. Infant warming bag on delivery table
  4. Infant placed into warming bag then wrapped in a towel
  5. Assistant to deliver preps cord clamps
  6. Registered Nurse (RN) notifies provider at 30 seconds
  7. Cord clamped and cut
  8. Infant handed off to waiting staff
  9. Exceptions: Placental separation, cord stops pulsating, need for immediate resuscitation, all would result in clamping prior to 30 seconds
Experimental: Cord Milking

Infants randomized to the cord milking group will follow the protocol below:

  1. Infant held at or below level of perineum (vaginal delivery) or incision (cesarean delivery)
  2. Infant held and the cord is milked from perineum to infant four times
  3. Assistant to deliver preps cord clamps
  4. Cord clamped and cut
  5. Infant handed off to waiting staff
See description in cord milking arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hemoglobin and Hematocrit values (H/H) in NICU
Time Frame: NICU admission to discharge, expected average of 50 days
All H/H values in the neonatal intensive care unit (NICU) will be recorded.
NICU admission to discharge, expected average of 50 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal transfusions
Time Frame: Birth to discharge, expected average of 50 days
The incidence of transfusions between the two groups will be compared.
Birth to discharge, expected average of 50 days
Necrotizing enterocolitis
Time Frame: Birth to discharge, expected average of 50 days
The incidence of necrotizing enterocolitis between the two groups will be compared.
Birth to discharge, expected average of 50 days
Intraventricular hemorrhage
Time Frame: Birth to discharge, expected average of 50 days
The incidence of intraventricular hemorrhage between the two groups will be compared.
Birth to discharge, expected average of 50 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: Birth to discharge, expected average of 50 days
The length of NICU stay between the two arms will be compared.
Birth to discharge, expected average of 50 days
Survival to discharge
Time Frame: Birth to discharge, expected average of 50 days
The rate of infant survival until discharge will be recorded for both groups.
Birth to discharge, expected average of 50 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Kathleen Smith, MD PhD, TriHealth Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

July 8, 2018

Study Completion (Actual)

July 8, 2018

Study Registration Dates

First Submitted

March 13, 2014

First Submitted That Met QC Criteria

March 17, 2014

First Posted (Estimate)

March 19, 2014

Study Record Updates

Last Update Posted (Actual)

December 28, 2018

Last Update Submitted That Met QC Criteria

December 27, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on Cord Milking

3
Subscribe